Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Christina Gianniou"'
Autor:
Hauraz Haji, Christina Gianniou, Troels Brynskov, Torben L. Sørensen, Rasmus Olsen, Marie Krogh Nielsen
Publikováno v:
Haji, H, Gianniou, C, Brynskov, T, Sørensen, T L, Olsen, R & Krogh Nielsen, M 2023, ' Association between structural and functional treatment outcomes in neovascular age-related macular degeneration ', Acta Ophthalmologica, vol. 101, no. 2, pp. 177-184 . https://doi.org/10.1111/aos.15233
PURPOSE: The administration frequency of intravitreal anti-vascular endothelial growth factor (anti-VEGF) in neovascular age-related macular degeneration (AMD) have been widely discussed. The primary objective of the study was to explore the associat
Autor:
C. Besse-Hayat, J. Bijon, Aude Ambresin, F. Spertini, D. Hohl, Christina Gianniou, E. Moret, S. Bogiatzi, Irmela Mantel
Publikováno v:
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, vol. 260, no. 3, pp. 1005-1014
Purpose To describe a series of non-immediate drug hypersensitivity reactions after intravitreal anti-vascular endothelial growth factors (anti-VEGFs). Patients and methods Retrospective report of 6 patients with cutaneous non-immediate drug hypersen
Publikováno v:
Therapeutics and clinical risk management, vol. 14, pp. 1387-1390
Therapeutics and Clinical Risk Management
Therapeutics and Clinical Risk Management, Vol Volume 14, Pp 1387-1390 (2018)
Therapeutics and Clinical Risk Management
Therapeutics and Clinical Risk Management, Vol Volume 14, Pp 1387-1390 (2018)
Aleksandra Petrovic,1,2 Christina Gianniou,1,2 Kattayoon Hashemi,1,2 Georgios Kymionis1,2 1Department of Ophthalmology, University of Lausanne, Jules-Gonin Eye Hospital, Lausanne, Switzerland; 2Cornea and Refractive Surgery Department, Lausanne, Swit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e28d0533da652f8f9665560c04658a95
https://serval.unil.ch/notice/serval:BIB_B061E0824195
https://serval.unil.ch/notice/serval:BIB_B061E0824195
Publikováno v:
Retina. 35:1195-1201
To investigate the visual acuity results of eyes with neovascular age-related macular degeneration and refractory fluid despite monthly treatment with ranibizumab, and to investigate differences between refractory subretinal fluid and intraretinal cy
Publikováno v:
The British Journal of Ophthalmology
British Journal of Ophthalmology, vol. 98, no. 9, pp. 1192-1196
British Journal of Ophthalmology, vol. 98, no. 9, pp. 1192-1196
AIMS: The purpose of this study was to clinically validate an individually planned treatment regimen for neovascular age-related macular degeneration (nAMD), termed, observe and plan. This regimen was based on the predictability of an individual's ne
Publikováno v:
Retina (Philadelphia, Pa.). 36(1)
To compare the effects of converting to aflibercept therapy with continuing ranibizumab therapy in eyes with neovascular age-related macular degeneration requiring monthly ranibizumab treatment.Patients were selected from the 104 patients (115 eyes)
Publikováno v:
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 253(8)
Purpose: To investigate the functional outcome of eyes with neovascular AMD (nAMD) and subretinal fluid (SRF) refractory to treatment with ranibizumab. Methods: Retrospective chart review of consecutive treatment-refractory SRF in nAMD despite monthl
Autor:
Christina Gianniou, Doris Decugis, A. Deli, W Ferrini, Aude Ambresin, Ali Dirani, Irmela Mantel, Laetitia Marchionno
Publikováno v:
Eye. 29:450-451
The purpose of this study was to report the 2-year outcome of an individually tailored ‘observe-and-plan’ treatment regimen for neovascular age-related macular degeneration (nAMD), and to investigate its clinical value in terms of functional outc